Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  LeMaitre Vascular, Inc.    LMAT

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
39.39(c) 37.49(c) 37.29(c) 36.57(c) 37.49(c) Last
116 375 163 114 130 229 119 047 107 481 Volume
-0.48% -4.82% -0.53% -1.93% +2.52% Change
More quotes
Financials (USD)
Sales 2020 127 M - -
Net income 2020 20,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 37,9x
Yield 2020 -
Sales 2021 146 M - -
Net income 2021 23,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 33,4x
Yield 2021 -
Capitalization 763 M 763 M -
Capi. / Sales 2020 5,99x
Capi. / Sales 2021 5,22x
Nbr of Employees 467
Free-Float 78,2%
More Financials
Company
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's... 
More about the company
Notations Surperformance© of LeMaitre Vascular, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about LEMAITRE VASCULAR, INC.
11/18LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/11LEMAITRE VASCULAR : to Present at the Jefferies Virtual London Healthcare Confer..
AQ
11/11LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Confe..
GL
11/06LEMAITRE VASCULAR : Management's Discussion and Analysis of Financial Condition ..
AQ
11/04LEMAITRE VASCULAR : to Present at Upcoming Investor Conferences
AQ
11/04LeMaitre Vascular to Present at Upcoming Investor Conferences
GL
10/29LEMAITRE : 3Q Earnings Snapshot
AQ
10/29LEMAITRE VASCULAR INC : Results of Operations and Financial Condition, Financial..
AQ
10/29LEMAITRE VASCULAR : Announces Q3 2020 Financial Results
AQ
10/29LeMaitre Vascular Announces Q3 2020 Financial Results
GL
10/09LEMAITRE VASCULAR : Will Announce Third Quarter 2020 Earnings Results on October..
AQ
10/09LeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on Octobe..
GL
08/31LeMaitre Vascular to Present at Upcoming Investor Conferences
GL
08/31LEMAITRE VASCULAR : to Present at Upcoming Investor Conferences
AQ
08/26LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
More news
News in other languages on LEMAITRE VASCULAR, INC.
2019LEMAITRE VASCULAR INC : Veröffentlichung des Jahresergebnisses
2019LEMAITRE VASCULAR INC : publication des résultats annuels
More news
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 41,40 $
Last Close Price 37,49 $
Spread / Highest target 30,7%
Spread / Average Target 10,4%
Spread / Lowest Target -6,64%
EPS Revisions
Managers
NameTitle
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts President & Director
Trent G. Kamke Senior Vice President-Operations
Joseph P. Pellegrino CFO, Secretary, Treasurer & Director
Jonathan W. Ngau Vice President-Information Technology
Sector and Competitors